{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:08:27Z","timestamp":1791144507784,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) affects over 30% of the global adult population and has been increasingly recognized as an adverse prognostic factor for colorectal cancer (CRC) liver metastasis (CRLM). However, the underlying immune mechanisms remain incompletely understood. This review provides a comprehensive synthesis of how NAFLD-induced lipotoxicity reshapes the hepatic immune microenvironment to create a \u201cfertile soil\u201d for CRC metastatic colonization. We delineate a hierarchical immunosuppressive network involving: (1) lipotoxic apoptosis of CD4+ T cells, depleting the helper T cell pool; (2) expansion and functional reinforcement of regulatory T cells (Tregs) through multiple mechanisms (IL-10\/TGF-\u03b2\/IL-35, CD25-mediated IL-2 competition, CTLA-4 engagement, and granzyme B\/perforin production); (3) M2 polarization of tumor-associated macrophages; and (4) recruitment of myeloid-derived suppressor cells (MDSCs) via the CXCL5\/CXCR2 axis, which suppress CD8+ T cell function. These processes collectively promote CD8+ T cell exhaustion (marked by PD-1, LAG-3, TIM-3 upregulation) and spatial mismatch with metastatic foci. Importantly, we discuss the emerging evidence linking NAFLD-driven immune dysregulation to reduced responsiveness to immune checkpoint inhibitors, while acknowledging the current limitations in direct clinical validation. By integrating mechanistic insights with therapeutic perspectives, this review offers new targets for risk stratification and combination immunotherapy in the growing NAFLD population. Non-alcoholic fatty liver disease.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1863647","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:39:45Z","timestamp":1782711585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["NAFLD-associated immune remodeling in colorectal cancer liver metastasis: mechanisms and implications for immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[{"name":"Health Management Center, Geriatric Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Gu","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Geriatric Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152539","article-title":"Prognostic factors in colorectal liver metastases: an exhaustive review of the literature and future prospectives","volume":"17","author":"Conticchio","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2025.100872","article-title":"The emerging role of blood-based biomarkers in early detection of colorectal cancer: a systematic review","volume":"42","author":"Shweikeh","year":"2024","journal-title":"Cancer Treat Res Commun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2025.102652","article-title":"The association between metabolic-associated fatty liver diseases and risk of colorectal polyps, neoplasia, and cancer: a systematic review and meta-analysis of over 56 million individuals","volume":"49","author":"Azimi","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101222","article-title":"Steatohepatitis alters lymphocytes cytotoxicity and localization, accelerating colorectal liver metastases","volume":"69","author":"Yehezkel","year":"2025","journal-title":"Neoplasia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1705503","article-title":"Novel regulators of hepatic macrophages in liver fibrosis","volume":"16","author":"Tang","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2025.2603580","article-title":"Serum interferon gamma-induced protein 10 in obese non-diabetic patients with metabolic dysfunction-associated steatotic liver disease","volume":"61","author":"Fouad","year":"2026","journal-title":"Scand J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1708240","article-title":"Decoding the heterogeneity of liver-resident macrophages in chronic liver diseases: therapeutic responses to immunomodulatory strategies","volume":"16","author":"Ouyang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155909","article-title":"Kr\u00fcppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4\u03b1-mediated metabolic pathways","volume":"155","author":"Pan","year":"2024","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001371","article-title":"Metabolic reprogramming of immune cells in MASH","author":"Ma","year":"2025","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000864","article-title":"Dual roles of T cells in metabolic dysfunction-associated steatohepatitis pathogenesis and liver fibrosis: from inflammation to therapeutic targets","volume":"9","author":"Chen","year":"2025","journal-title":"Hepatol Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597204","article-title":"Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Supruniuk","year":"2025","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105031","article-title":"Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma","volume":"101","author":"Wang","year":"2024","journal-title":"EBioMedicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2024.0085","article-title":"Increased peripheral interleukin-35 suppresses CD4(+) T and CD8(+) T-cell activity in patients living with chronic human immunodeficiency virus-1 infection","volume":"38","author":"Li","year":"2025","journal-title":"Viral Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000542404","article-title":"Overcoming GABA-induced Treg suppression of immunity by ABAT to augment CD8+T cell antitumor immune response in liver cancer","volume":"186","author":"Han","year":"2025","journal-title":"Int Arch Allergy Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010465","article-title":"Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion","volume":"13","author":"Kilic","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221391","article-title":"CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis","volume":"220","author":"Xu","year":"2023","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03410-w","article-title":"Murine regulatory T cells utilize granzyme B to promote tumor metastasis","volume":"72","author":"Tibbs","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115847","article-title":"PD-1(+)\/CXCR6(+)CD8(+)T lymphocytes promote MASLD malignant progression through inflammatory and immune dysregulation","volume":"168","author":"Wang","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.04.016","article-title":"Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity","volume":"41","author":"Yan","year":"2023","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30693","article-title":"NOD-like receptor C4 inflammasome regulates the growth of colon cancer liver metastasis in NAFLD","volume":"70","author":"Ohashi","year":"2019","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00165","article-title":"The engagement between MDSCs and metastases: partners in crime","volume":"10","author":"Trovato","year":"2020","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.04.008","article-title":"Concomitant NAFLD facilitates liver metastases and PD-1-refractory by recruiting MDSCs via CXCL5\/CXCR2 in colorectal cancer","volume":"18","author":"Yang","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201937","article-title":"Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid","volume":"190","author":"Dunham","year":"2013","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112364","article-title":"Hepatic iNKT cells facilitate colorectal cancer metastasis by inducing a fibrotic niche in the liver","volume":"28","author":"Nater","year":"2025","journal-title":"iScience"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-104934","article-title":"Metabolic dysfunction-associated steatotic liver disease and colorectal neoplasms risk: a global propensity score-matched retrospective cohort study","volume":"15","author":"Aldiabat","year":"2025","journal-title":"BMJ Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2419888122","article-title":"Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer","volume":"122","author":"Alencar","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012345","article-title":"Targeting SQLE-mediated cholesterol metabolism to enhance CD8(+) T cell activation and immunotherapy efficacy in hepatocellular carcinoma","volume":"13","author":"Qiao","year":"2025","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:39:46Z","timestamp":1782711586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1863647"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1863647","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1863647"}}